Canary Speech vs Ellipsis Health (2026)
Two vocal biomarker companies that took opposite routes to market. Canary Speech sells the model rather than the application. Its engine extracts roughly 2,590 acoustic and linguistic features from the voice every ten milliseconds, and partners embed it in their own products. That choice shows in what it publishes: model cards naming its certifications with versions, an intended use statement, named compatible record systems, and a documented oversight structure with a threshold, an override and a route to a person. Ellipsis Health sells the finished conversation. Sage is an agentic care manager calling members for health plans and at risk providers, handling enrollment, assessments, surveys and care coordination, powered by what the company calls its Empathy Engine, built on patented vocal biomarker technology and trained on millions of live clinical calls. Its governance has a named process: an ethics committee approving healthcare applications and a clinical team validating every update before release. So the choice is rarely between them. One is bought by a product team with something to build; the other is bought by a plan with members to reach.
- You are building, not buying a workflow: the engine embeds in your product, and the model card tells your team what it does and does not cover.
- The oversight design is published end to end, with a stated threshold, an override and a route to a person.
- Epic, Cerner, Oracle Health and Meditech are named as compatible record systems, and its certifications are named with their versions.
- You need member contact at scale: inbound and outbound calls for enrolment, assessments, surveys and care coordination, aimed at the American payer market.
- The governance process is named twice over, an ethics committee approving healthcare applications and a clinical team validating every product update before deployment.
- The voice work is productised already, so nothing has to be built around it.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Canary Speech and Ellipsis Health are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Canary Speech | Ellipsis Health |
|---|---|---|
| Primary category | Behavioral Health AI | Patient Voice Agents |
| Founded | 2017 | 2017 |
| Headquarters | Provo, Utah, United States | San Francisco, California |
| Website | canaryspeech.com | ellipsishealth.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Canary Speech its top capability grade on AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Set against Ellipsis Health, Canary Speech grades higher on several axes, including Autonomy and Oversight Model, Model and Technology Transparency and Clinical and Operational Evidence. Its thinnest published disclosure sits on Commercial Transparency. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, September 2026
The AI Health Index awards Ellipsis Health its top capability grade on AI Centrality. Set against Canary Speech, Ellipsis Health grades higher on Commercial Transparency. Its thinnest published disclosure sits on AI Liability and Recourse. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, September 2026
Questions buyers ask
Should we choose Canary Speech or Ellipsis Health?
On the axes where the AI Health Index separates them, Canary Speech grades higher on several axes, including Autonomy and Oversight Model, Model and Technology Transparency and Clinical and Operational Evidence, and Ellipsis Health grades higher on Commercial Transparency. Canary Speech leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Canary Speech and Ellipsis Health differ most?
The widest separation the AI Health Index records between Canary Speech and Ellipsis Health is on AI Liability and Recourse, where Canary Speech grades B and Ellipsis Health grades D. That axis sits in the Regulatory and Compliance group, so it should carry the most weight for a buyer whose binding constraint is where regulatory exposure sits and who carries it.
Where do Canary Speech and Ellipsis Health grade the same?
The AI Health Index grades Canary Speech and Ellipsis Health the same on several axes, including AI Centrality, Model Supply Chain Disclosure and HIPAA and BAA Posture. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Canary Speech and Ellipsis Health not disclosed?
At the last review, at least one of Canary Speech and Ellipsis Health published thin or absent detail on AI Liability and Recourse and Commercial Transparency. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Remote Monitoring & Chronic Care page.
Both assert that their voice models work across populations and neither publishes per group results, which is the standing gap in this technology: speech varies by accent, dialect, age and first language, and medication alters the very features these models read. Ask both for per group figures. Canary's published performance is vendor authored and honest about its numbers, with commercial outcome evidence still missing, and its compliance position has no contracting statement behind it.
Ellipsis publishes no escalation criterion for a voice agent making outbound calls to recently discharged members, and its consent question is the sharper one: the vendor states that vocal cue detection runs in production, so a member who called about a prescription may have an inference drawn from their voice and should be told where it goes. Neither publishes a price.